| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Oct―20 |
Hybrid Models of COVID-19 Epidemic Waves with Evaluation of Changes in the Affinity of Spike Protein Binding to the ACE2 Cellular Receptor |
A. Yu. Perevaryukha |
| 2 |
[GO] |
2025―Mar―17 |
Antiviral Effect Against SARS-CoV-2 of Dinitrosyl Iron Complex Solutions when Inhaled to Syrian Hamsters in a “Nose-Only” Chamber |
A. V. Shipovalov, A. F. Vanin, N. A. Tkachev, O. V. Pyankov, N. B. Asanbaeva, S. V. An’kov, et al. (+4) E. G. Bagryanskaya, A. M. Baklanov, S. V. Valiulin, M. E. Stekleneva |
| 3 |
[GO] |
2025―Mar―06 |
Assessment of Binding Affinity in the Complexes of ACE2 with RBD of the S Protein of SARS-CoV Using Convolutional Neural Networks |
E. A. Bogdanova, A. V. Chernukhin, K. V. Shaitan, V. N. Novoseletsky |
| 4 |
[GO] |
2024―Mar―07 |
Analysis of the Development of Trends in the Current Epidemic Situation during Spread of the New SARS-CoV-2 Strains and Factors of their Regional Differentiation |
A. Yu. Perevaryukha |
| 5 |
[GO] |
2023―Dec―13 |
SARS-CoV-2 Pandemic as a Predator-Prey System: Biophysical, Social and Heliophysical Factors of the Spread of Local Epidemics |
M. V. Ragulskaya |
| 6 |
[GO] |
2023―Aug―25 |
Single SARS Virus Mutation as a Possible Cause of the Predominance of Asymptomatic COVID-19 Infection Forms |
I. D. Kolesin, E. M. Zhitkova |
| 7 |
[GO] |
2023―Aug―25 |
Part of Anti-COVID Therapy Based on a Theoretical Model Describing Mechanics of Contact Interaction between Coronavirus and Cell Membrane |
N. A. Koltcova |
| 8 |
[GO] |
2023―Mar―03 |
High Dose Inhalation with Gaseous Nitric Oxide in COVID-19 Treatment |
E. V. Pechyonkin, A. V. Kovrizhkin, A. V. Pekshev, A. B. Vagapov, N. A. Sharapov, A. F. Vanin |
| 9 |
[GO] |
2023―Mar―03 |
SARS-COV-2 Coronavirus Papain-like Protease PLpro as an Antiviral Target for Inhibitors of Active Site and Protein-Protein Interactions |
P. V. Ershov, E. O. Yablokov, Y. V. Mezentsev, G. N. Chuev, M. V. Fedotova, S. E. Kruchinin, A. S. Ivanov |
| 10 |
[GO] |
2022―Dec―19 |
Sodium Selenite As Potential Adjuvant Therapy for COVID-19 |
T. M. Huseynov, R. T. Guliyeva, S. H. Jafarova, N. H. Jafar |
| 11 |
[GO] |
2022―Dec―19 |
Antiviral Activity of Nitrosonium Cations against SARS-CoV-2 on a Syrian Hamster Model |
A. V. Shipovalov, A. F. Vanin, O. V. Pyankov, E. G. Bagryanskaya, V. D. Mikoyan, N. A. Tkachev, et al. (+2) N. A. Asanbaeva, V. Ya. Popkova |
| 12 |
[GO] |
2022―Jun―29 |
Mathematical Analysis of a COVID-19 Epidemic Model by Using Data Driven Epidemiological Parameters of Diseases Spread in India |
D. Pal, D. Ghosh, P. K. Santra, G. S. Mahapatra |
| 13 |
[GO] |
2021―Oct―15 |
Radiation Inactivation of Coronavirus Infection Pathogen by the Example of Transmissible Gastroenteritis Virus |
V. N. Morozov, A. N. Mukhin, M. A. Kolyvanova, A. V. Belousov, Y. A. Bushmanov, T. V. Grebennikova, A. S. Samoylov |
| 14 |
[GO] |
2021―Apr―27 |
Gaseous Nitric Oxide and Dinitrosyl Iron Complexes with Thiol-Containing Ligands as Potential Medicines that Can Relieve COVID-19 |
A. F. Vanin, A. V. Pekshev, A. B. Vagapov, N. A. Sharapov, V. L. Lakomkin, A. A. Abramov, et al. (+2) A. A. Timoshin, V. I. Kapelko |
| 15 |
[GO] |
2020―Oct―19 |
Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm |
Yu. D. Nechipurenko, A. A. Anashkina, O. V. Matveeva |
